5-Aza-2′-deoxycytidine induced growth inhibition of leukemia cells through modulating endogenous cholesterol biosynthesis

Molecular and Cellular Proteomics

Volumn 11, Issue 7, 2012, Pages

  Zhang, Fan ^a   Dai, Xiaoxia ^a   Wang, Yinsheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CHOLESTEROL; DIPEPTIDYL PEPTIDASE IV; GERANYLTRANSFERASE; SMALL INTERFERING RNA; SQUALENE SYNTHASE; ANTINEOPLASTIC ANTIMETABOLITE; AZACITIDINE; DPP4 PROTEIN, HUMAN; DRUG DERIVATIVE;

ARTICLE; CANCER INHIBITION; CELL STRAIN HL 60; CELL SURVIVAL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOTOXICITY; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MELANOMA CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; BIOSYNTHESIS; CELL PROLIFERATION; CELL STRAIN K 562; DNA METHYLATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; MELANOMA; METABOLISM; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEROL; DIPEPTIDYL PEPTIDASE 4; DNA METHYLATION; EPIGENESIS, GENETIC; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GERANYLTRANSTRANSFERASE; HL-60 CELLS; HUMANS; JURKAT CELLS; K562 CELLS; MASS SPECTROMETRY; MELANOMA; PROTEOMICS; RNA, SMALL INTERFERING;

EID: 84863799085     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.016915     Document Type: Article

References (31)

1. Holliday, R. (1987) The inheritance of epigenetic defects. Science 238, 163-170
2. Jones, P. A., and Baylin, S. B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428 (Pubitemid 34587077)
3. Yoo, C. B., and Jones, P. A. (2006) Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug Discov. 5, 37-50
4. Jones, P. A., and Taylor, S. M. (1980) Cellular-differentiation, cytidine analogs and DNA methylation. Cell 20, 85-93 (Pubitemid 10117303)
5. Christman, J. K. (2002) 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21, 5483-5495
6. Ghoshal, K., Datta, J., Majumder, S., Bai, S., Kutay, H., Motiwala, T., and Jacob, S. T. (2005) 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol. Cell. Biol. 25, 4727-4741 (Pubitemid 40705775)
7. Kaminskas, E., Farrell, A., Abraham, S., Baird, A., Hsieh, L. S., Lee, S. L., Leighton, J. K., Patel, H., Rahman, A., Sridhara, R., Wang, Y. C., and Pazdur, R. (2005) Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes. Clin. Cancer Res. 11, 3604-3608 (Pubitemid 40685574)
8. Plimack, E. R., Kantarjian, H. M., and Issa, J. P. (2007) Decitabine and its role in the treatment of hematopoietic malignancies. Leuk. Lymphoma 48, 1472-1481 (Pubitemid 47272797)
9. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
10. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
11. Kersey, P. J., Duarte, J., Williams, A., Karavidopoulou, Y., Birney, E., and Apweiler, R. (2004) The International Protein Index: an integrated database for proteomics experiments. Proteomics 4, 1985-1988 (Pubitemid 38880363)
12. Deleted in proof
13. Martínez, F., Eschegoyen, S., Briones, R., and Cuellar, A. (1988) Cholesterol Increase in mitochondria - a new method of cholesterol incorporation. J. Lipid Res. 29, 1005-1011
14. Madden, E. A., Bishop, E. J., Fiskin, A. M., and Melnykovych, G. (1986) Possible role of cholesterol in the susceptibility of a human acute lymphoblastic leukemia cell line to dexamethasone. Cancer Res. 46, 617-622 (Pubitemid 16145411)
15. Dong, X., Xiong, L., Jiang, X., and Wang, Y. (2010) Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in Jurkat-T cells induced by doxorubicin. J. Proteome Res. 9, 5943-5951
16. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCt method. Methods 25, 402-408 (Pubitemid 34164012)
17. Nilsson, C. L., Dillon, R., Devakumar, A., Shi, S. D., Greig, M., Rogers, J. C., Krastins, B., Rosenblatt, M., Kilmer, G., Major, M., Kaboord, B. J., Sarracino, D., Rezai, T., Prakash, A., Lopez, M., Ji, Y., Priebe, W., Lang, F. F., Colman, H., and Conrad, C. A. (2010) Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1 alpha Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells. J. Proteome Res. 9, 430-443
18. Goldstein, J. L., and Brown, M. S. (1990) Regulation of the mevalonate pathway. Nature 343, 425-430
19. Takenawa, T., and Suetsugu, S. (2007) The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat. Rev. Mol. Cell Biol. 8, 37-48 (Pubitemid 46012013)
20. Bernheim-Groswasser, A., Wiesner, S., Golsteyn, R. M., Carlier, M. F., and Sykes, C. (2002) The dynamics of actin-based motility depend on surface parameters. Nature 417, 308-311 (Pubitemid 34534715)
21. Lin, Y. H., Park, Z. Y., Lin, D., Brahmbhatt, A. A., Rio, M. C., Yates, J. R., 3rd, and Klemke, R. L. (2004) Regulation of cell migration and survival by focal adhesion targeting of Lasp-1. J. Cell Biol. 165, 421-432 (Pubitemid 38649916)
22. Dufour, S., Ramprasad, O. G., Srinivas, G., Rao, K. S., Joshi, P., Thiery, J. P., and Pande, G. (2007) Changes in cholesterol levels in the plasma membrane modulate cell signaling and regulate cell adhesion and migration on fibronectin. Cell Motil. Cytoskel. 64, 199-216
23. Sun, M., Northup, N., Marga, F., Huber, T., Byfield, F. J., Levitan, I., and Forgacs, G. (2007) The effect of cellular cholesterol on membranecytoskeleton adhesion. J. Cell Sci. 120, 2223-2231 (Pubitemid 47074126)
24. Vitols, S., Norgren, S., Juliusson, G., Tatidis, L., and Luthman, H. (1994) Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells. Blood 84, 2689-2698
25. Dimitroulakos, J., Nohynek, D., Backway, K. L., Hedley, D. W., Yeger, H., Freedman, M. H., Minden, M. D., and Penn, L. Z. (1999) Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach. Blood 93, 1308-1318 (Pubitemid 29076146)
26. Li, H. Y., Appelbaum, F. R., Willman, C. L., Zager, R. A., and Banker, D. E. (2003) Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Blood 101, 3628-3634 (Pubitemid 36857952)
27. Tsuji, T., Sugahara, K., Tsuruda, K., Uemura, A., Harasawa, H., Hasegawa, H., Hamaguchi, Y., Tomonaga, M., Yamada, Y., and Kamihira, S. (2004) Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells. Int. J. Hematol. 80, 254-260 (Pubitemid 39410933)
28. Turcot, V., Bouchard, L., Faucher, G., Tchernof, A., Deshaies, Y., Pérusse, L., Bélisle, A., Marceau, S., Biron, S., Lescelleur, O., Biertho, L., and Vohl, M. C. (2011) DPP4 gene DNA methylation in the omentum is associated with its gene expression and plasma lipid profile in severe obesity. Obesity 19, 388-395
29. Wesley, U. V., Albino, A. P., Tiwari, S., and Houghton, A. N. (1999) A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J. Exp. Med. 190, 311-322 (Pubitemid 29374829)
30. Claus, R., and Lübbert, M. (2003) Epigenetic targets in hematopoietic malignancies. Oncogene 22, 6489-6496 (Pubitemid 37372329)
31. De Meester, I., Korom, S., Van Damme, J., and Scharpé, S. (1999) CD26, let it cut or cut it down. Immunol. Today 20, 367-375 (Pubitemid 29356431)